Orchard Therapeutics
ORTX
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)
Orchard Therapeutics (ORTX) - Cash on Hand
Cash on Hand as of September 2023 : $0.12 B
According to Orchard Therapeutics
's latest financial reports the company has $0.12 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Orchard Therapeutics - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.14 B | -34.69% |
| 2021-12-31 | $0.22 B | 14.67% |
| 2020-12-31 | $0.19 B | -40.94% |
| 2019-12-31 | $0.32 B | -3.23% |
| 2018-12-31 | $0.33 B | 273.76% |
| 2017-12-31 | $89.85 M | 2469.52% |
| 2016-12-31 | $3.49 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $5.29 M | -95.78% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 0.00% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | 353.31% | 🇺🇸 USA |
 Novocure
NVCR | $0.91 B | 626.09% | Jersey |